Tag: biosimilars

Healthcare

The Federal Election, Medicare & You

With the Federal Election being held tomorrow, the issue of Medicare and (by extension) Private Health Insurance has once again been thrown into the spotlight with both the Coalition and Labor promising to keep Medicare public and ensure that our system and ensure that our system is free from privatisation. We spoke to Dr Paul…

1 Jul 2016, by Informa Insights

Healthcare

Can India become a biosimilar powerhouse?

Melbourne, 8th February 2011 - Indian manufacturers are ideally placed to capitalise on the growing biosimilars market, according to independent market analyst Datamonitor. Although the biosimilars market is in its infancy, Datamonitor research suggests that Indian manufacturers are well positioned to capitalise on the future growth of this market both domestically and internationally. Alistair Sinclair,…

8 Feb 2011, by Informa Insights

Healthcare

Implications of Nivestim’s approval on the Australian biosimilars market

Melbourne – 6th October 2010 – Biosimilars in Australia: Nivestim approval opens up local filgrastim biosimilars market. Lisette Oversteegen, Lead Analyst, comments: “Although the recent approval of biosimilar filgrastim is a positive development for the Australian industry, the proposed biosimilars pricing regulations may slow uptake”. Compared with Europe, where several biosimilar products of three different…

6 Oct 2010, by Informa Insights